CLSD - Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX
2023-12-14 08:28:42 ET
More on Clearside Biomedical
- Clearside Biomedical, Inc. (CLSD) Q3 2023 Earnings Call Transcript
- BioCryst, Clearside Biomedical in pact for diabetic eye disease
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical
For further details see:
Clearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AX